|
FAM122A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.88657986402541E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12132525487141E-14 |
| Normal-vs-Stage2 |
4.48360000238068E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
8.446100E-02 |
| Stage1-vs-Stage3 |
8.088400E-02 |
| Stage1-vs-Stage4 |
1.497730E-03 |
| Stage2-vs-Stage3 |
5.963500E-03 |
| Stage2-vs-Stage4 |
2.762000E-04 |
| Stage3-vs-Stage4 |
1.015750E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-15 |
| Normal-vs-AfricanAmerican |
2.97990000452941E-08 |
| Normal-vs-Asian |
1.69142477801643E-12 |
| Caucasian-vs-AfricanAmerican |
5.605200E-01 |
| Caucasian-vs-Asian |
9.303800E-01 |
| AfricanAmerican-vs-Asian |
6.356000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.63180580159406E-12 |
| Male-vs-Female |
1.699050E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63002944475465E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.51410000001928E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.850200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.470200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.945200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.448200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.470800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.707000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.843600E-03 |
| Classical-VS-Follicular |
1.063240E-01 |
| Classical-VS-Other |
7.162800E-01 |
| Classical-VS-Normal |
1.67821312402339E-12 |
| Tall-VS-Follicular |
7.001100E-04 |
| Tall-VS-Other |
5.336200E-01 |
| Tall-VS-Normal |
1.62492241884138E-12 |
| Follicular-VS-Other |
4.301200E-01 |
| Follicular-VS-Normal |
4.04432043410452E-12 |
| Other-VS-Normal |
2.795300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.857400E-03 |
|
|
